featured
Obeticholic Acid Use in Patients With Primary Biliary Cholangitis and Suboptimal Response to Ursodeoxycholic Acid
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Alimentary Pharmacology & Therapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effectiveness and Safety of Obeticholic Acid in a Southern European Multicenter Cohort of Patients With Primary Biliary Cholangitis and Suboptimal Response to Ursodeoxycholic Acid
Aliment. Pharmacol. Ther. 2021 Feb 01;53(4)519-530, E Gomez, L Garcia Buey, E Molina, M Casado, I Conde, M Berenguer, F Jorquera, MA Simón, A Olveira, M Hernández-Guerra, M Mesquita, J Presa, P Costa-Moreira, G Macedo, JI Arenas, J Manuel Sousa, J Ampuero, RM Morillas, A Santos, A De Carvalho, J Uriz, JA Carrión, M Luisa Gutiérrez, E Pérez-Fernández, CM Fernández-RodríguezFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.